Aspectos relacionados à utilização de antirretrovirais em pacientes de alta complexidade no estado do Rio de Janeiro, Brasil

Madruga, Lívia Gonçalves dos Santos Lima; Silva, Gabriela Veloso Vieira da; Alves, Vinicius Abib Ramos; Velarde, Luis Guillermo Coca; Azeredo, Thiago Botelho; Setúbal, Sergio; Brito, Monique Araújo de; Lima, Elisangela da Costa.
Ciênc. Saúde Colet. (Impr.) ; 23(11): 3649-3662, Oct. 2018. tab, graf
Artículo en Portugués | LILACS | ID: biblio-974742

Documentos relacionados

  1. Lenacapavir: A Novel Long-Acting Capsid Inhibitor for HIV.
  2. Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design.
  3. The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review.
  4. Preparation of a Key Intermediate En Route to the Anti-HIV Drug Lenacapavir.
  5. Strategies for an HIV cure: progress and challenges.
  6. Human immunodeficiency virus infection challenges: Current therapeutic limitations and strategies for improved management through long-acting injectable formulation.
  7. Acceptance Rate and Reasons for Rejection of Long Acting Injectable Antiretrovirals.
  8. Chemometrics as a valuable tool for evaluating interactions between antiretroviral drugs and food.
  9. Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study.
  10. Assessment of satisfaction with antiretroviral drugs and the need for long-acting injectable medicines among people living with HIV in Japan and its associated factors: a prospective multicenter cross-sectional observational study.